Information Provided By:
Fly News Breaks for May 31, 2017
ARRY
May 31, 2017 | 10:54 EDT
Piper Jaffray analyst Edward Tenthoff raised his price target for Array BioPharma to $14 after the company partnered binimetinib and encorafenib with Ono Pharmaceuticals in Japan and South Korea. The partnership delivers on a stated goal, Tenthoff tells investors in a research note. He reiterates an Overweight rating on the shares.